Background: Large-cell neuroendocrine carcinoma (LCNEC) is a rare type of lung cancer with a poor prognosis. Due to its rarity, molecular characterization of LCNEC is not well elucidated. We aim to understand the genomic and immunologic landscape of LCNEC to identify molecular alterations and relevant biological pathways with potential therapeutic value.
Publications
Genomic and immunologic characterization of large-cell neuroendocrine carcinoma of the lung.
– Caris Life Sciences
Download Publication